Rebuttal to Circulating IL-6 Levels in Chronic Obstructive Pulmonary Disease

• References

• 1 Wedzicha JA, Seemungal TAR, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, Jeffries DJ, Meade TW. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000; 84: 210-5.
• 2 Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors and long term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 324: 1076-9.
• 3 Meade TW. Fibrinogen in ischaemic heart disease. Eur Heart J 1995; 16 Suppl A 31-5.
• 4 Ferroni P, Basili S, Alessandri C, Vieri M, Martini F, Belogi A, Pulcinelli FM, Cordova C, Gazzaniga PP. Proinflammatory cytokines and haemostatic system in patients with chronic obstructive pulmonary disease. Platelets 1997; 8: 255-9.
• 5 Burstein SA. Effects of interleukin-6 on megakaryocytes and on canine platelet function. Stem Cells Dayt 1994; 12: 386-93.
• 6 Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP, van der Poll T. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996; 76: 738-42.
• 7 Ferroni P, Basili S, Pulcinelli FM, Pettirossi G, Alessandri C, Violi F, Gazzaniga PP, Cordova C. In vivo thrombin generation and platelet hyperactivity in patients with chronic obstructive pulmonary disease. Platelets 1994; 5: 276-8.
• 8 Ferroni P, Basili S, Martini F, Vieri M, Labbadia G, Cordova C, Alessandri C, Gazzaniga PP. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Invest Med 2000; 48: 21-7.